Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
551.78B
Market cap551.78B
Price-Earnings ratio
26.47
Price-Earnings ratio26.47
Dividend yield
2.27%
Dividend yield2.27%
Average volume
7.80M
Average volume7.80M
High today
$230.83
High today$230.83
Low today
$228.04
Low today$228.04
Open price
$228.43
Open price$228.43
Volume
4.15M
Volume4.15M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$149.04
52 Week low$149.04

Stock Snapshot

The current Johnson & Johnson(JNJ) stock price is $229.22, with a market capitalization of 551.78B. The stock trades at a price-to-earnings (P/E) ratio of 26.47 and offers a dividend yield of 2.3%.

During the trading session on 2026-05-19, Johnson & Johnson(JNJ) shares reached a daily high of $230.83 and a low of $228.04. At a current price of $229.22, the stock is +0.5% higher than the low and still -0.7% under the high.

Trading volume for Johnson & Johnson(JNJ) stock has reached 4.15M, versus its average volume of 7.8M.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $149.04.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $149.04.

JNJ News

24/7 Wall St. 4h
This Will Be Johnson and Johnson's Stock Price in 2027

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Johnson & Johnson wasn't one of them. Get them here FREE . Johnson & Johnson’s oncology...

This Will Be Johnson and Johnson's Stock Price in 2027
Nasdaq 6h
Meet the Dividend King With a Higher Credit Rating Than the U.S. Government

Key Points Johnson & Johnson's business can perform well under the most challenging conditions. The company's credit rating and dividend track record provide...

Meet the Dividend King With a Higher Credit Rating Than the U.S. Government
CNBC 8h
Modular data center builder Armada raises $230 million, to build Arizona factory with new investor Johnson Controls - CNBC

...

Modular data center builder Armada raises $230 million, to build Arizona factory with new investor Johnson Controls - CNBC

Analyst ratings

63%

of 27 ratings
Buy
63%
Hold
29.6%
Sell
7.4%

More JNJ News

Simply Wall St 9h
Johnson & Johnson Trial Results Add Context To Valuation And Pipeline Outlook

Johnson & Johnson (NYSE:JNJ) reported positive Phase 2 data for JNJ-1900 (NBTXR3) in non small cell lung cancer. The company also released network meta analysi...

Johnson & Johnson Trial Results Add Context To Valuation And Pipeline Outlook
Simply Wall St 3d
Has Johnson & Johnson Run Too Far After A 54% One-Year Surge?

Wondering if Johnson & Johnson at around US$226.71 is still a fair deal, or if the stock has already run too far for comfort. The stock closed at US$226.71, wi...

Has Johnson & Johnson Run Too Far After A 54% One-Year Surge?
Simply Wall St 4d
Assessing Johnson & Johnson Valuation After Earnings Beat Guidance Hike And Ongoing Dividend Growth

Johnson & Johnson (JNJ) just reported quarterly earnings and sales ahead of expectations, supported by both its Innovative Medicines and MedTech segments, while...

Assessing Johnson & Johnson Valuation After Earnings Beat Guidance Hike And Ongoing Dividend Growth
24/7 Wall St. 4d
If You Have $480,000 Saved at 67 and Just Sold a Restaurant for $1.1 Million Cash, Here Is the Income Plan That Actually Holds

If You Have $480,000 Saved at 67 and Just Sold a Restaurant for $1.1 Million Cash, Here Is the Income Plan That Actually Holds By Drew Wood Published May 15, 1...

If You Have $480,000 Saved at 67 and Just Sold a Restaurant for $1.1 Million Cash, Here Is the Income Plan That Actually Holds
Simply Wall St 5d
How Investors Are Reacting To Johnson & Johnson Expanding Its Coronary Lithotripsy Device Portfolio

Earlier this week, Johnson & Johnson’s Shockwave Medical unit launched the Shockwave C2 Aero coronary intravascular lithotripsy catheter globally, offering impr...

How Investors Are Reacting To Johnson & Johnson Expanding Its Coronary Lithotripsy Device Portfolio
24/7 Wall St. 6d
Russell 1000 Dividend ETF Hits $125 as Johnson & Johnson Leads The Safety Test

Russell 1000 Dividend ETF Hits $125 as Johnson & Johnson Leads The Safety Test By John Seetoo Published May 13, 9:01AM EDT Quick Read ONEY’s largest holdings—...

Russell 1000 Dividend ETF Hits $125 as Johnson & Johnson Leads The Safety Test
TipRanks 6d
Leerink upgrades J&J to Outperform on new drug momentum

Leerink upgraded Johnson & Johnson to Outperform from Market Perform with a price target of $265, up from $252. The firm says the company’s “strong new drug mom...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.